These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13538531)

  • 1. A comparison of passive protection tests against intranasal and intracerebral challenges with Bordetella pertussis.
    DOLBY JM; STANDFAST AF
    Immunology; 1958 Apr; 1(2):144-56. PubMed ID: 13538531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis.
    STANDFAST AF
    Immunology; 1958 Apr; 1(2):135-43. PubMed ID: 13538530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination during the incubation period. II. A comparison of intranasal and intracerebral infection with H. pertussis.
    KRATOCHVILOVA A; JELINEK J; RASKA K
    J Hyg Epidemiol Microbiol Immunol; 1958; 2(1):23-8. PubMed ID: 13598892
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral infection of mice with Haemophilus pertussis and passive protection by hyperimmune rabbit sera.
    BROWN AM
    J Gen Microbiol; 1958 Feb; 18(1):48-57. PubMed ID: 13525627
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs.
    Elahi S; Thompson DR; Strom S; O'Connor B; Babiuk LA; Gerdts V
    J Infect Dis; 2008 Aug; 198(3):384-92. PubMed ID: 18540802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
    Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
    Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 5'-MGB hybridization probes for detection of Bordetella pertussis and Bordetella parapertussis using different real-time PCR instruments.
    Afonina I; Metcalf M; Mills A; Mahoney W
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):429-32. PubMed ID: 18093785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non-neurological diseases.
    Fiszer U; Tomik B; Grzesiowski P; Krygowska-Wajs A; Walory J; Michałowska M; Palasik W
    Acta Neurol Scand; 2004 Aug; 110(2):113-7. PubMed ID: 15242419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S; van Furth R; Mooi FR
    Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
    Cherry JD; Xing DX; Newland P; Patel K; Heininger U; Corbel MJ
    Clin Infect Dis; 2004 Feb; 38(4):502-7. PubMed ID: 14765342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.
    Heininger U; Riffelmann M; Leineweber B; Wirsing von Koenig CH
    Pediatr Infect Dis J; 2009 May; 28(5):443-5. PubMed ID: 19319020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
    Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
    Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
    Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.